Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
NCT00024167Phase 3Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Apr 2002
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Strontium chloride in prostate cancer (PCa), sponsored by University of Texas MD Anderson Cancer Center. Started Apr 2002; status: terminated.
02
Drugs
Strontium chloride
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00024167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00024167.